The shares are listed on the New York Stock Exchange

Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 15,715,900 shares of Class A common stock of Hinge Health, Inc., of which 8,522,528 shares were issued and sold by the company and 7,193,372 shares were sold by the selling stockholders, at $32.00 per share, for total gross proceeds of approximately $503 million. The shares sold included 2,049,900 shares sold by the selling stockholders pursuant to the underwriters’ over-allotment option. The Class A common stock is listed on the New York Stock Exchange under the symbol “HNGE.”

Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The company has designed its platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation—and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere.

The Davis Polk corporate team included partners Alan F. Denenberg and Shane Tintle and associates Dana Lueck-Mammen, Brendon S. Brown and Ashley Jaworoski. Partner David R. Bauer and associate Gabrielle Mazero provided intellectual property advice. Counsel Christopher A. Baratta and associate Ted Lee provided tax advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post